Fig. 5
From: Dendritic cell hybrid nanovaccine for mild heat inspired cancer immunotherapy
Biodistribution of LDC@ZnP NPs in vivo. A In vivo images of Free DIR, L@ZnP NPs and LDC@ZnP NPs treated mice at different time points. B Fluorescence quantization of in vivo tumors at different time points (n = 4), *p < 0.05, **p < 0.01, ***p < 0.001. C Ex vivo images of Free DIR, L@ZnP NPs, and LDC@ZnP NPs treated tumors and TDLNs at 48 h post injection (n = 4). D Fluorescence quantization of ex vivo tumors at 48 h post injection (n = 4), *p < 0.05, **p < 0.01. E Fluorescence quantitation of Free DIR, L@ZnP NPs and LDC@ZnP NPs in ex vivo TDLNs (n = 4), *p < 0.05